A Randomized, Open-label, Single Dose, 3-way Crossover Study to Evaluate the Drug-drug Interaction Between Aceclofenac 200 mg and Esomeprazole 20 mg in Healthy Male Volunteers

Trial Profile

A Randomized, Open-label, Single Dose, 3-way Crossover Study to Evaluate the Drug-drug Interaction Between Aceclofenac 200 mg and Esomeprazole 20 mg in Healthy Male Volunteers

Recruiting
Phase of Trial: Phase I

Latest Information Update: 28 Apr 2017

At a glance

  • Drugs Aceclofenac (Primary) ; Esomeprazole (Primary)
  • Indications Ankylosing spondylitis; Osteoarthritis; Rheumatic disorders; Rheumatoid arthritis
  • Focus Pharmacokinetics
  • Sponsors Dong Wha Pharmaceutical
  • Most Recent Events

    • 28 Apr 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top